In this issue:
- 2013–2019 trends and risk factors for HIV in UK gay/bisexual MSM
- Weight gain and related comorbidities following ART initiation in the 2000s
- Cabotegravir for preventing HIV in cisgender men and transgender women
- Impact of COVID-19 on HIV testing and provision of care across four continents
- Anal HPV and HSILs in men according to HIV status, sexuality and age
- Starting long-acting cabotegravir + rilpivirine as injections or with oral lead-in for HIV-1
- Factors associated with SARS-COV-2 diagnosis and severe COVID-19 in HIV
- Long-acting cabotegravir + rilpivirine every 2 months in HIV-1
- Humoral and cellular immune responses to Pfizer COVID-19 vaccine in HIV
- High resistance in Enterobacterales in HIV
Please login below to download this issue (PDF)